Home › Funds › TCG Crossover Management, LLC › LBRX

TCG Crossover Management, LLC position in LBRX

LB PHARMACEUTICALS INC · Health Care

TCG Crossover Management, LLC reported holding 1,447,310 shares of LBRX (LB PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$47.0M, representing 1.13% of its reported portfolio and ranking #24 among its reported holdings. TCG Crossover Management, LLC has disclosed LBRX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)1.45M sh
Reported value held$46.97M
Portfolio Weight1.13%
First reportedQ3 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TCG Crossover Management, LLC's LBRX position evolved

TCG Crossover Management, LLC first disclosed a stake in LBRX in Q3 2025 at 1,745,016 shares (US$27.6M). The position peaked in Q2 2026 at 1,447,310 shares, worth US$47.0M. Across 4 filings, TCG Crossover Management, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,447,310 shares valued at US$47.0M — a reduction of -392,179 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2025 1.75M $27.55M New
Q4 2025 1.75M $38.84M Hold
Q1 2026 1.84M $45.28M Add
Q2 2026 1.45M $46.97M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LBRX and 13F data

LBRX (LB PHARMACEUTICALS INC) is a Health Care company. 110 other funds we track also report a position in LBRX — the largest reported positions include Deep Track Capital, LP (US$108.8M), RA CAPITAL MANAGEMENT, L.P. (US$71.7M), Trails Edge Capital Partners, LP (US$49.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LBRX

All LBRX fund holders →

FAQ

How long has TCG Crossover Management, LLC held LBRX?

TCG Crossover Management, LLC has disclosed LBRX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is TCG Crossover Management, LLC's current position in LBRX?

As of Q2 2026, TCG Crossover Management, LLC holds 1.45M shares of LBRX (LB PHARMACEUTICALS INC), valued at $46.97M, representing 1.13% of its reported portfolio and ranking #24.

Has TCG Crossover Management, LLC been buying or selling LBRX?

In the latest 13F filing (Q2 2026), TCG Crossover Management, LLC reduced its position in LBRX. The position peaked in Q2 2026 at 1.45M shares.

Which other funds hold LBRX?

Other major institutional holders of LBRX include Deep Track Capital, LP, RA CAPITAL MANAGEMENT, L.P., Trails Edge Capital Partners, LP, among 110 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.